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The Chemokine Receptor CXCR3 Promotes CD8+ T Cell
Accumulation in Uninfected Salivary Glands but Is Not
Necessary after Murine Cytomegalovirus Infection
Soﬁa Caldeira-Dantas,*,†,‡ Thomas Furmanak,* Corinne Smith,* Michael Quinn,*
Leyla Y. Teos,x Adam Ertel,{ Drishya Kurup,* Mayank Tandon,x Ilias Alevizos,x and
Christopher M. Snyder*
Recent work indicates that salivary glands are able to constitutively recruit CD8+ T cells and retain them as tissue-resident
memory T cells, independently of local infection, inﬂammation, or Ag. To understand the mechanisms supporting T cell recruit-
ment to the salivary gland, we compared T cell migration to the salivary gland in mice that were infected or not with murine CMV
(MCMV), a herpesvirus that infects the salivary gland and promotes the accumulation of salivary gland tissue-resident memory
T cells. We found that acute MCMV infection increased rapid T cell recruitment to the salivary gland but that equal numbers of
activated CD8+ T cells eventually accumulated in infected and uninfected glands. T cell recruitment to uninfected salivary glands
depended on chemokines and the integrin a4. Several chemokines were expressed in the salivary glands of infected and uninfected
mice, and many of these could promote the migration of MCMV-speciﬁc T cells in vitro. MCMV infection increased the expression
of chemokines that interact with the receptors CXCR3 and CCR5, but neither receptor was needed for T cell recruitment to the
salivary gland during MCMV infection. Unexpectedly, however, the chemokine receptor CXCR3 was critical for T cell accumu-
lation in uninfected salivary glands. Together, these data suggest that CXCR3 and the integrin a4 mediate T cell recruitment to
uninfected salivary glands but that redundant mechanisms mediate T cell recruitment after MCMV infection. The Journal of
Immunology, 2018, 200: 000–000.
T
hesalivary gland is an exocrine organ composed mostly of
acinar cells producing a water-based ﬂuid, which is rich is
mucus, ions, and enzymes, that is released in the oral cavity
via a network of epithelial ducts. Because of this, several viruses,
including all human betaherpesviruses and gammaherpesviruses,
infect the salivary gland and use saliva as amajor route of transmission
to new hosts (1–3). How the immune system responds to pathogens in
the salivary gland and prevents or limits viral shedding remain poorly
deﬁned. In addition, how pathogens alter the salivary gland envi-
ronment by infection is unknown.
CMV is a betaherpesvirus that infects most organs in the body
but undergoes prolonged replication in the salivary gland. CMV
infects the acinar and ductal epithelial cells in the salivary gland
and, thus, is shed into saliva during replication (4–6). Using the
mouse CMV (MCMV) model, it was shown .40 y ago
that lymphocytes enter the salivary gland, resulting in the death of
MCMV-infected epithelial cells (7, 8). MCMV also establishes
latency in the salivary gland and readily reactivates in this
tissue during periods of immune suppression, particularly when
CD8+ T cells have been depleted (9). It might be assumed
that lymphocytes are drawn to the salivary gland in response to the
CMV infection. Interestingly, however, recent data from several
laboratories, including our own, suggested that Ag-stimulated
CD8+ T cells could be recruited to the salivary gland constitu-
tively after MCMV infection or even without speciﬁc infection of
the gland (10–12). MCMV-speciﬁc T cell populations were
abundant in the salivary gland after MCMV infection where they
adopted an intraepithelial localization and expressed CD69 and
CD103 (10, 11), markers of tissue-resident memory T cells (TRM).
TRM are memory T cell subsets that are retained in tissues inde-
pendently of the circulating pool of T cells, thus providing a rapid
defense against reactivation of a latent infection or local reinfec-
tion of a previously encountered pathogen (13, 14). Surprisingly,
even in vitro–activated T cells could migrate to the salivary gland
where they developed into protective TRM in the complete absence
of infection or speciﬁc inﬂammation (10–12), leading to the de-
scription of the salivary gland as a “sink” for CD8+ TRM (10).
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It is unknown whether local inﬂammation or Ag can enhance the
recruitment or retention of CD8+ TRM in the salivary gland.
However, this ability of salivary glands to attract and retain pro-
tective numbers of CD8+ TRM, without a local infection or in-
ﬂammation, is quite unexpected. In most other sites in the body,
tissue-localized inﬂammation and/or Ag is critical for the efﬁcient
recruitment of T cells or their retention as TRM (15–24). The best-
studied example of the interplay among Ag, inﬂammation, and
TRM formation is the skin, where inﬂammation alone is sufﬁcient
to enable T cell egress from the blood and formation of TRM
phenotype cells (22). Interestingly, although infection at one skin
site could lodge T cells at distant skin locations (23, 25), the ef-
ﬁciency was very poor without local inﬂammation, and local Ag
enhanced the maintenance of TRM populations and shaped the
speciﬁcity of the cells that were retained (16, 23, 24). Thus, al-
though Ag and inﬂammation within a particular skin site are not
absolutely required for TRM formation, they markedly enhance the
number of protective TRM that are established in the skin. Other
tissues have been less well studied, but a similar theme is repeated.
In the vaginal mucosa, CD8+ T cell entry during HSV infection
was poor unless CD4+ T cells in the tissue promoted local che-
mokines in an IFN-g–dependent manner (17). In the lungs, the
formation and maintenance of protective numbers of TRM after
multiple infections, including MCMV, depended on Ag and in-
fection of the lungs (26, 27). The brain is even more restrictive,
requiring infection or Ag for any detectable TRM formation (20).
In fact, other than the salivary gland, only the small intestine has
been described as permissive of TRM formation and maintenance
in an Ag and infection–independent manner (28). Thus, the sali-
vary gland and the small intestine may be uniquely capable of
recruiting and retaining T cells without any speciﬁc infection.
Although many studies have addressed the mechanisms of T cell
recruitment to the intestine [e.g., (28–31)], very little is known
about the mechanisms of T cell recruitment to the salivary gland.
A recent study demonstrated that systemic inﬂammation could
induce expression of the cellular adhesion molecule VCAM-1 on
vascular endothelial cells in the salivary gland and that this
boosted the recruitment of activated T cells via the integrin a4
(32), which pairs with the b1 integrin to form the ligand for
VCAM-1. At ﬁrst glance, this supports the notion that inﬂam-
mation will enhance T cell recruitment to the salivary gland.
However, TRM formation and maintenance were not studied.
Moreover, the chemokines that recruit T cells to the salivary gland
remain undeﬁned.
We examined CD8+ T cell recruitment to the salivary gland in
the presence or absence of active MCMV infection. Our data
conﬁrm and extend recent observations that uninfected salivary
glands were permissive to the recruitment and retention of acti-
vated CD8+ T cells in a manner dependent on the integrin a4.
Moreover, active MCMV infection of the salivary glands increased
the rapid recruitment of activated T cells. Remarkably, however,
inﬂammation induced by MCMV infection did not enhance the
number of TRM that were ultimately lodged in the salivary gland.
Indeed, many chemokines abundantly expressed in the salivary
gland of infected and uninfected mice could attract MCMV-
speciﬁc T cells in vitro, including CXCL9 (monokine induced
by IFN-g) and CXCL10 (IFN-inducible 10 KDa protein), ligands
for the receptor CXCR3. CXCR3 is a chemokine receptor that has
been described to be important for CD8+ T cell migration to a
variety of tissues, typically in the context of inﬂammation and
infection (33). Unexpectedly, we found that CXCR3 expression by
T cells was critical for efﬁcient T cell accumulation in the salivary
gland in uninfected mice but was dispensable for their accumu-
lation in the salivary gland during MCMV infection. These data
establish a mechanism for the surprisingly efﬁcient recruitment of




All mice were purchased from The Jackson Laboratory and bred in-house.
C57BL/6 (B6), B6.SJL-PtprcaPepcb/BoyJ (CD45.1), B6.PL-Thy1a/CyJ
(Thy1.1), and IFN-g–knockout (KO) (B6.129S7-Ifngtm1Ts/J) mice
were used as recipients in the adoptive-transfer experiments and to
assess chemokine expression in the salivary gland. OT-I transgenic
mice [B6-Tg(TcraTcrb)1100Mjb/J] were bred with CD45.1 mice,
CXCR3-KO mice (B6.129P2-Cxcr3tm1Dgen/J), and CCR5-KO mice
(B6.129P2-Ccr5tm1Kuz/J) to generate congenic wild-type (WT)
OT-Is, CXCR3-KO OT-Is, or CCR5-KO OT-Is T cells.
MCMV-K181 virus (kindly provided by Ed Mocarski) was used in
Figs. 1–6. MCMV–SL8-015 or MCMV–K181–tfr–OVA (both referred to
here as MCMV-OVA) have been described (34, 35) and were used to
expand OT-I T cells prior to the secondary adoptive transfer in Fig. 4A and
4B and in Figs. 7 and 8A–D. Finally, MCMV-K181 was used in Fig. 8F.
Infections were performed using 2 3 105 PFU and the i.p. route (100 ml
per injection) in all experiments, with the exception of Fig. 1, in which
some of the infections were performed via the intranasal (i.n.) or footpad
(f.p.) route in a total volume of 20–25 ml per inoculation after anesthe-
sia with isoﬂurane. MCMV-K181, MCMV-OVA, and MCMV–SL8-015
were produced as described (34, 36–38). All protocols were approved by
the Thomas Jefferson University Institutional Animal Care and Use
Committee.
Lymphocyte isolation and FACS staining
For all of the experiments, i.v. Ab injections were performed, as described
in (39, 40) without perfusion, to distinguish between vasculature-localized
(I.V.+) and parenchyma-localized (I.V.2) CD8+ T cells. In brief, mice were
injected i.v. with 3 mg of an anti-CD8a Ab (clone 53-6.7 conjugated to
BV650 or BV421) 3 min before sacriﬁce. Blood was collected from the
retro-orbital sinus or from the chest cavity, after cutting the pulmonary
vein at sacriﬁce, and the organs were collected in media containing an
unlabeled CD8a Ab (clone 53-6.7). Total CD8+ T cells were identiﬁed by
CD8b staining during the phenotypic analyses, as described below.
Lymphocytes from the blood, spleen, inguinal lymph nodes, subman-
dibular salivary glands (referred to as “salivary glands” throughout), kid-
neys, and lungs were isolated, as described previously (40), with minimal
modiﬁcations. Brieﬂy the mucosal organs were minced using a gentle-
MACS Dissociator (Miltenyi Biotec) and incubated at 37˚C for 1–1.5 h in
digestion media containing 1 mg/ml collagenase type IV, 5 mM CaCl2, 50
mg/ml DNase I, and 10% FBS in RPMI 1640. Salivary glands were sus-
pended in 40% Percoll and overlaid on top of a 75% Percoll layer, whereas
the kidneys and lungs were suspended in 40% Percoll. Suspensions were
centrifuged at 6003 g for 25–30 min, and the lymphocytes were collected
from the 75/40 interface (salivary glands) or pellets (kidney and lung).
Phenotypic analyses of T cells were performed using the following Abs:
CD8a (clone 53-6.7), CD8b (YTS156.7.7), CD69 (clone H1.2F3), CD103
(clone 2E7), CD44 (clone IM7), KLRG1 (clone 2F1), CXCR3 (clone
CXCR3-173), CXCR4 (clone L276F12), CXCR6 (clone SA051D1), and
CX3CR1 (clone SA011F11). OT-I T cells were identiﬁed by their congenic
markers with CD45.1 (clone A20) and/or CD45.2 (clone 104) and by the
TCR chains Va2 (clone B20.1) and Vb5 (clone MR9-4). In Fig. 9E
(Exp.2), donor cells were also identiﬁed by the Thy1.2 marker (clone 30-
H12). All Abs were purchased from BioLegend or BD Biosciences. All
MHC-tetramers, loaded with peptides from M38, were provided by the
National Institutes of Health Tetramer Core Facility (http://tetramer.yerkes.
emory.edu/) and were used as described (41). A tetramer loaded with the
B8R peptide derived from vaccinia virus (VACV) was used as a negative
control for the tetramer staining following a MCMV infection. All samples
were collected on a BD LSRFortessa or LSR II ﬂow cytometer and ana-
lyzed using FlowJo software (TreeStar). The gating strategy is shown in
Supplemental Fig. 1.
In vitro T cell activation and expansion
OT-I T cells were activated in vitro based on the protocol described (12),
with modiﬁcations. Brieﬂy, splenocytes from OT-I mice were harvested,
and 4 3 106 cells per milliliter were cultured with 1 mg/ml SIINFEKL
peptide for 2 d. On the second day, the cells were resuspended to 5 3 105
cells per milliliter and incubated with 0.03 U/ml IL-2 that was renewed
every 2 d for a total of 4–5 d until the adoptive transfer.
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All of the adoptive transfers were performed via retro-orbital injections in a
volume of 100 ml between congenic donor and recipient mice (differing in
CD45.1/.2 or Thy1.1/1.2 expression).
In vitro–activated T cells. For the adoptive transfers in Figs. 2–4C, 8E, 8F,
and 9 and Supplemental Fig. 2, in vitro–activated CD8+ CD44+ OT-I
T cells were transferred to congenic naive recipients or recipients in-
fected for 9 wk (Fig. 2) or 11 d (Fig. 3) with MCMV-K181 (lacking OVA).
For treatment with pertussis toxin (PTx), OT-I T cells were suspended
at a concentration of 1.5 3 107 cells per milliliter and treated or not with
50 ng/ml PTx (Sigma-Aldrich) for 1 h at 37˚C prior to transfer. In Fig. 8F,
WT and CCR5-KO OT-I T cells were mixed and cotransferred to B6 mice
that were previously infected with MCMV-K181 for 11 d. The mixture of
donor cells was treated with anti-CXCR3 blocking Ab (clone CXCR3-
173) or isotype-control Ab (polyclonal Armenian hamster IgG) at a con-
centration of 30 mg per 4 3 107 cells for 15 min. Recipient mice were also
treated with the anti-CXCR3 Ab or isotype control (250 mg per mouse) via
i.p. injections on day 22, day 0 (day of transfer), and day 2. Blocking Abs
and isotype controls were purchased from Bio X Cell. The same ap-
proach was used in Fig. 9, but only WT OT-I T cells were transferred to
naive recipients.
In vivo–activated T cells. For in vivo activation (Figs. 4A, 4B, 7, 8A–D),
naive OT-I T cells were transferred into naive congenic recipients, fol-
lowed by infection with MCMVexpressing the cognate SIINFEKL peptide
(MCMV–SL8-015 or K181–MCMV–OVA) 1–3 d after transfer. The
number of cells transferred is indicated in each ﬁgure legend. In Fig. 4A
and 4B, 5 3 104 OT-I T cells were transferred into congenic recipients to
produce large numbers of OT-I T cells for a secondary transfer by day 5
postinfection. In this experiment, OT-I T cells were recovered from the
spleen 5 d postinfection, treated for 30 min with 60 mg/ml anti-a4 (clone
PS/2), anti-a4b7 (clone DATK32), or the respective isotype controls, and
transferred to a new group of infection-matched or naive recipients. The
recipients were treated on the day of the transfer with 300 mg of each Ab or
isotype control via i.p. injection. Organs were collected 2 d after the
secondary transfer, and the tissues were processed as described above.
Cell-proliferation assays
To assess proliferation of OT-I T cells in naive or MCMV-infected mice
(Supplemental Fig. 2), OT-I T cells were labeled with a cell tracer dye
(CellTrace Violet or CFSE), following the manufacturer’s instructions,
before the adoptive transfer. Brieﬂy, cells were suspended at a concen-
tration of 106 cells per milliliter and incubated with 5 mM CellTrace Violet
for 20 min or were suspended at a concentration of 1 3 107 cells per
milliliter and incubated with 1 mM CFSE for 10 min.
Transwell migration assays
For Transwell migration assays, CD8+ T splenocytes were isolated from
MCMV-K181–infected mice (7 d) using an EasySep biotin selection kit
(STEMCELL Technologies) and biotinylated Abs against erythrocytes
(Ter119), CD19 (6D5), NK1.1 (PK136), I-A/I-E (M5/114.15.2), and CD4
(GK1.4), following the manufacturer’s protocol. Typically, CD8+ T cells
were 80–90% pure following this protocol. Puriﬁed cells were resuspended
in RPMI 1640 media containing 2% BSA and 25 nM HEPES buffer
(migration media) at a concentration of 5 3 106 cells per milliliter and
were incubated for 1 h at 37˚C. Subsequently, 5 3 105 cells, in a total
volume of 100 ml, were added to the upper chamber of a 6.5-mm Poly-
carbonate Transwell system (Corning) with a pore diameter of 5 mm.
Chemokines (all from BioLegend) were diluted in migration media and
added to the lower chamber at titrating concentrations in a total volume of
600 ml (three or four replicate wells per concentration). Control (media
alone) samples, without chemokines in the lower chamber of the Transwell
plates, were included on every plate to account for plate-to-plate variations
in T cell migration. All tests were run in duplicate or triplicate on every
plate. Chemokine concentrations shown in Fig. 6 represent the optimal
migration over control (media alone) wells based on replicate titrations of
each chemokine. Cells in the Transwell plates were incubated for 1.5 h at
37˚C. At the end of the incubation, 200 ml of cells from the bottom
chamber were mixed with counting beads (CountBright Absolute Counting
Beads; Invitrogen), whereas the remaining volume was used for FACS
analyses of tetramer-binding cells. Cells were collected by ﬂow cytometry,
as above.
Reverse transcriptase quantitative PCR
For assessment of chemokine receptors expressed by T cells in Fig. 7C and
7D, OT-I T cells were transferred to B6 mice that were subsequently
infected with MCMV–K181–OVA (n = 3 mice). Seven days postinfection,
spleen and salivary glands were collected, and CD8+ T cells were enriched
using an EasySep biotin selection kit (STEMCELL Technologies), as de-
scribed above for the Transwell assays. OT-I T cells were sorted based on
the congenic markers CD45.1 and CD45.2. RNA was extracted from the
sorted OT-I T cells (Fig. 7C, 7D) and whole salivary glands of naive B6 or
IFN-g–KO mice (Fig. 9F) using an RNeasy Mini Kit (QIAGEN), and
cDNA was recovered using a High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). In both cases, the b-actin and chemokine re-
ceptor transcripts expressed were detected on a StepOnePlus system
(Applied Biosystems) using predesigned quantitative PCR assays (Inte-
grated DNA Technologies) and FAM for detection. The relative concen-
tration of chemokine receptors on these cells was determined by
comparing the chemokine receptor signal with the b-actin signal for
the same sample on the same plate; data are expressed as the 22DCT value
[e.g., 2 2(CT value for chemokine A 2 CT value internal reference control A)].
RNA sequencing
For the RNA sequencing (RNA-Seq) analysis, salivary glands were col-
lected from naive mice or from mice that were infected with 2 3 105 PFU
MCMV-K181 i.p. for 14 d, and RNA was obtained using a miRCURY
RNA Isolation Kit Tissues (Exiqon).
RNA cleanup and depletion of ribosomal RNA for RNA-Seq analysis. Prior
to cDNA library preparation, RNA samples were puriﬁed using RNAClean
& Concentrator (catalog number R1015; Zymo Research) and treated with
DNase I to remove contaminating genomic DNA. Validation of RNA
quality and concentration was determined using an RNA 6000 Pico Kit
(catalog number 5067-1513; Agilent Technologies) for the 2100 Bio-
analyzer instrument (Agilent Technologies). Four micrograms of total
RNA per sample were used as input for the depletion of ribosomal RNA
(RiboMinus kit, catalog number A15020; Ambion), yielding 6% recovery
of input RNA, on average.
RNA-Seq library preparation and sequencing. Library preparation was
performed using an Ion Total RNA Seq Kit v2 (Thermo Fisher Scientiﬁc),
according to the manufacturer’s protocol. The yield and size scatter of the
cDNA libraries were evaluated using High Sensitivity DNA Chips (catalog
number 5067-4626; Agilent Technologies) on a 2100 Bioanalyzer instru-
ment. The barcoded cDNA libraries were diluted to a ﬁnal concentration of
100 pM and used for template preparation on an Ion Chef System using an
Ion PI Hi-Q Chef Kit (catalog number A27198; Thermo Fisher Scientiﬁc).
Sequencing was performed on the Ion Proton Sequencer system using Ion
PI Chip Kit v3 (catalog number A26771; both from Thermo Fisher Sci-
entiﬁc). Sequenced data were preprocessed on an Ion Torrent server with
Torrent Suite Software 4.4.3.
RNA-Seq data analysis. Ion Torrent single-end sequence reads were mapped
to the mm10 genome using Ion Torrent Torrent Server TMAP aligner,
version 4.4.11. Gene abundances were estimated by counting strand-speciﬁc
reads using the Subread package featureCounts tool; reads with mapq of 0 or
multiple mappings were ﬁltered out (42). Reads overlapping more than one
gene feature were not counted because the transcript of origin could not be
conﬁdently determined, as recommended by the Subread/featureCounts
manual. Resulting read counts were then used to analyze differential ex-
pression between infected and uninfected samples using the DESeq2
package for R/Bioconductor, with default settings (43). For additional data
exploration and visualization, reads per kilobase per million reads esti-
mates were calculated from featureCounts results.
Gene Set Enrichment Analysis (GSEA) was also performed to identify
up- and downregulated gene groups among available pathway and gene
ontology annotations (44). Mouse gene symbols were converted to their
human orthologs, obtained from MGI on March 3, 2017, for compatibility
with GSEA. GSEA preranked analysis was performed using the list of
available human orthologs, the DESeq2 test statistic as the ranking metric,
and GSEA enrichment score set to “classic,” as described in the GSEA
FAQ.
The sequencing data have been submitted to the National Center for
Biotechnology Information Gene Expression Omnibus (https://www.ncbi.
nlm.nih.gov/geo/) under accession number GSE107338.
ELISAs for chemokine expression
Whole salivary glands of naive B6 and IFN-g–KO mice were collected in
PBS with 10 ml/ml Halt Protease Inhibitor Cocktail (Thermo Fisher Sci-
entiﬁc) and homogenized for two 30-s cycles in a mini bead beater. After
centrifugation (14,0003 g for 15 min), the supernatant was stored at280˚
C. The total protein concentration was determined using a Quick Start
Bradford Protein Assay (Bio-Rad). Samples were normalized to 8 mg/ml
total protein. The concentration of CXCL9 in each sample was quantiﬁed
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in duplicate using a CXCL9 (MIG) ELISA kit (Thermo Fisher Scientiﬁc),
according to the manufacturer’s speciﬁcations.
Statistical analysis
Differences in absolute numbers were determined after log10 transforma-
tion, and the fold change was determined based on the ratios of the geo-
metric mean. The speciﬁc statistical test used for each experiment is
indicated in the ﬁgure legends. Prism 6 for Mac OS X was used to de-
termine the log10-transformed values and geometric mean, as well as to
perform the statistical analysis.
Results
The route of MCMV infection impacts CD8+ T cell migration to
the salivary gland but not the rate of TRM differentiation
We have previously shown that MCMV infection by the i.p. route
led to robust formation of TRM in the salivary gland postinfection
(11). However, factors outside of the tissue, such as the site of
T cell priming, may inﬂuence CD8+ T cell trafﬁcking and TRM
formation in some tissues (45–48). To determine whether the route
of MCMV infection inﬂuenced the migration of CD8+ T cells and
the formation of MCMV-speciﬁc TRM, we compared TRM num-
bers 14 d postinfection via the i.p., i.n., and f.p. routes. In this
experiment, and throughout, cells that were still within the cir-
culation were distinguished from those that had reached the pa-
renchyma by intravascular staining with anti-CD8 Abs, as
described in Materials and Methods. As shown in Fig. 1, MCMV-
speciﬁc T cells reached the parenchyma of the salivary gland after
all three routes of infection and developed the TRM phenotype.
Interestingly, infections by the i.n. and f.p. routes were associated
with lower overall numbers of MCMV-speciﬁc T cells in the
salivary gland, which reached statistical signiﬁcance after f.p.
infection. Notably, this effect was not due to an overall difference
between circulating populations, as reﬂected by the similar num-
ber of MCMV-speciﬁc T cells in the spleen at the same time point
after all three infections. Importantly, however, the frequency of
T cells that developed the TRM phenotype in the salivary gland
was identical after all three routes of infection (Fig. 1C), implying
that once T cells arrived in the gland, they were equally capable of
differentiating into TRM. In contrast, MCMV-speciﬁc TRM only
formed in the lung after i.n. infection (Fig. 1B, 1C), which con-
ﬁrms the results of a recent study (19). These data suggest that the
route of infection impacts the ability of T cells to reach the sali-
vary gland but not their differentiation into TRM.
Activated CD8+ T cells can enter the salivary gland and
develop the TRM phenotype even when a pre-established TRM
population is already present
Previous studies suggested that activated T cells could enter and
reside in naive uninfected salivary glands. Moreover, we previously
suggested that persistent MCMV infection resulted in continuous
recruitment and retention of new MCMV-speciﬁc TRM, long after
the primary infection had been resolved (11). To directly compare
these two conditions, we activated OT-I T cells in vitro and
transferred them to congenic mice that were naive or latently in-
fected with WT MCMV lacking OVA (9 wk postinfection,
Fig. 2A). WT MCMV was used in these experiments to assess the
impact of viral infection and the presence of unrelated TRM, as
well as to avoid the complication of Ag-driven T cell expansion of
the donor OT-I T cells. Two weeks after transfer, OT-I T cells had
reached the salivary gland in similar numbers in naive and latently
infected recipients (Fig. 2B), and similar frequencies of OT-I
T cells expressing CD69 and CD103, the markers of bona ﬁde
TRM, were observed in naive and infected salivary glands (Fig. 2C,
2D). Likewise, when naive or MCMV-infected mice were infected
with VACV, VACV-speciﬁc TRM (B8R tetramer
+) were present in
the salivary glands in similar numbers, and the frequency of TRM-
phenotype VACV-speciﬁc T cells was equivalent between groups
(data not shown). Thus, our data suggest that naive, acutely in-
fected, and latently infected salivary glands are all capable of
recruiting activated CD8+ T cells and supporting their differenti-
ation into TRM.
Acute MCMV infection promotes rapid CD8+ T cell
recruitment to the salivary gland but does not affect the overall
numbers of TRM-phenotype T cells
Although the above experiments demonstrate that infection and
inﬂammation are not needed for T cell recruitment to the salivary
gland and development of the TRM phenotype, MCMV infects the
salivary gland directly, and our data do not exclude a role for acute
inﬂammation in promoting the process. To directly compare T cell
migration to naive salivary glands and salivary glands with active
MCMV replication, in vitro–activated OT-I T cells were trans-
ferred to naive mice or mice infected 11 d previously with MCMV
(Fig. 3), a time when replicating MCMV can be detected in the
salivary glands after i.p. infection (11). For these experiments, we
infected mice with WT MCMV (lacking OVA) to test the role of
inﬂammation in the gland, again without the confounding issue of
FIGURE 1. MCMV-speciﬁc CD8+ T cells accumulate in the salivary
gland after several routes of MCMV infection. Mice were infected by i.p.,
i.n., and f.p. inoculation. Cells in the parenchyma or vasculature of each
tissue were distinguished by i.v. staining, as described in Materials and
Methods. (A) Absolute number of M38 tetramer+ CD8+ T cells from the
parenchyma of the salivary gland (SG) and lungs (LG) and from the
overall CD8b+ population of the spleen (SPL) 2 wk postinfection. (B)
Absolute number of CD103+ CD69+ M38 Tetramer+ cells in the SG and
LG from the data shown in (A). Data are from two independent experi-
ments (n = 6 for f.p. and i.p.; n = 5 for i.n.). Error bars represent the SEM.
(C) Concatenated FACS plots from one representative experiment (n = 2
for i.n.; n = 3 for i.p. and f.p.) of CD69 and CD103 expression of M38
Tetramer+ CD8+ T cells from the salivary gland (upper panels) and the
lungs (lower panel). The mean frequency6 SEM in the indicated quadrant
were calculated considering both experiments. *p , 0.05, one-way
ANOVA after log10 transformation of the absolute numbers.
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the transferred cells undergoing Ag-driven proliferation in infected
mice. An increased recruitment of OT-I T cells to the salivary gland,
but not other organs, was observed in the infected recipients early after
transfer (Fig. 3B), which was not due to higher T cell proliferation
rates in the infected glands (Supplemental Fig. 2). At later time points
(31 d after transfer), there was a reduction in the number of OT-I
T cells in the lung and the kidneys, as expected, due to the lack of
Ag, but not in the salivary gland. Remarkably, the early advantage in
FIGURE 2. CD8+ T cells with a TRM phenotype can form in the salivary glands of naive mice and mice latently infected with MCMV. (A) Schematic
diagram of the experimental design. Naive mice or mice that had been infected (i.p.) for 9 wk with WT MCMV (lacking OVA) were seeded with 3 3 106
in vitro–activated OT-I T cells and sacriﬁced 2 wk after transfer. (B) Absolute number of OT-I T cells from the parenchyma of the salivary gland (SG), lungs
(LG), and kidneys (KDN) and from the overall CD8b+ population of the spleen (SPL). (C) Frequency of CD103 and CD69 expression on OT-I T cells from
the parenchyma of the SG, LG, and KDN. Data are combined from two independent experiments (n = 7). (D) Concatenated FACS plots from a repre-
sentative experiment with frequency (mean 6 SEM) values considering all of the experiments. An unpaired t test was used to test for statistical signiﬁcance
between infected and naive mice within each organ. No signiﬁcant differences were found.
FIGURE 3. CD8+ TRM-phenotype cells can form and persist at similar numbers in salivary glands from MCMV-infected and naive mice. (A) Schematic
diagram of the experimental design. Naive mice or mice infected i.p. 11 d earlier with MCMV were seeded with 3 3 106 in vitro–activated OT-I T cells.
The recipients were sacriﬁced at 4 and 31 d after transfer. (B) Absolute number of OT-I T cells in the parenchyma of the salivary gland (SG), lung (LG), and
kidney (KDN) and from the CD8b+ cells of the spleen (SPL). (C and D) Frequency of CD103- and CD69-expressing OT-I T cells in the parenchyma of the
SG, LG, and KDN at 31 d after transfer. Data are combined from two experiments (n = 7 naive and n = 6 infected recipients at day 4, n = 6 naive and n = 6
infected at day 31). (D) Concatenated FACS plots of CD103 and CD69 expression of OT-I T cells in the SG from one representative experiment (n = 3 naive
and n = 3 infected recipients), with mean 6 SEM values considering all of the experiments. Error bars represent SEM. ***p , 0.001, unpaired t test after
log10 transformation of absolute numbers.
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T cell numbers recruited to the infected salivary gland was no
longer evident (Fig. 3B). Moreover, the frequency of OT-I TRM
present in the salivary gland was similar in infected and naive
recipients 31 d after transfer (Fig. 3C, 3D). Thus, surprisingly, our
data suggest that, although inﬂammation of the salivary gland
caused by MCMV infection resulted in an accelerated accumu-
lation of activated OT-I T cells in the gland shortly after transfer,
infection and inﬂammation provided no long-term advantage for
the formation or maintenance of CD8+ TRM.
CD8+ T cell homing to the salivary gland is mediated by a4b1
and chemokines at steady-state
Recent data from Woyciechowski et al. (32) have suggested that
the integrin a4b1 plays a critical role in T cell recruitment to the
salivary gland during systemic inﬂammation induced by i.v.
polyinosinic-polycytidylic acid treatment. We wondered whether
this mechanism would also contribute to T cell recruitment to
naive salivary glands. To test this, naive WT OT-I T cells were
transferred into congenic mice and driven to expand with MCMV-
OVA infection. Five days postinfection, splenic T cells containing
activated OT-I T cells were transferred to MCMV-K181 infection–
matched or naive recipients in the presence or absence of Abs to
block a4 integrin or a4b7 integrin. As expected, a4 blockade
greatly reduced the number of OT-I T cells in the salivary gland of
infected recipients 2 d after transfer (Fig. 4A) (32). Likewise, in
naive recipients, a4 blockade reduced the numbers of OT-I T cells
in the salivary gland and in the lamina propria of the small in-
testine compared with the group that received the isotype-control
Ab; these differences were not observed in the spleens of the same
animals (Fig. 4B). In contrast, the blockade of a4b7 had no sig-
niﬁcant impact on T cells in the salivary gland, despite inhibiting
OT-I T cell migration to the lamina propria of the small intestine
(Fig. 4B), as expected (30, 32, 49). In addition, preincubation of
OT-I T cells with retinoic acid, which strongly induces the a4b7
integrin (50), had no effect on salivary gland migration (data not
shown). The a4 integrin is known to pair with the b1 or b7 chain.
Therefore, these data suggest that a4b1 is important for the mi-
gration of activated CD8+ T cells to the salivary gland, regardless
of infection. These data also imply that the salivary gland ex-
presses sufﬁcient VCAM-1, the ligand for a4b1, independently of
local MCMV infection.
Chemokines are important for activating integrins and
promoting lymphocyte transendothelial migration. However, sev-
eral recent reports have implicated chemokine-independent
mechanisms of T cell recruitment (e.g., CD44, IL-33, or Ag)
(51–53). To test whether chemokines are mediators of CD8+ T cell
recruitment to the naive salivary gland, OT-I T cells were activated
in vitro and treated or not with PTx, which irreversibly inhibits
signaling through G protein–coupled receptors like chemokine
receptors (54–56). Untreated activated OT-I T cells migrated into
all organs, including the salivary gland, within 4 d of transfer, as
expected (Fig. 4C). In contrast, PTx treatment substantially re-
duced the numbers of OT-I T cells that migrated into the lymph
nodes (Fig. 4C), as previously shown (55, 56), as well as the
salivary gland and kidney (Fig. 4C). These data suggest that ac-
tivated CD8+ T cells migrate to naive salivary glands in response
to a chemokine signal.
Chemokines expressed in the salivary gland with or without
MCMV infection
To explore the chemokines expressed by the salivary gland in the
presence or absence of MCMV infection, we used RNA-Seq.
Salivary glands were extracted from naive mice or mice that
had been infected for 2 wk with MCMV strain K181. Perhaps not
surprisingly, the dominant changes in overall gene expression
could be traced back to immune responses, type I IFN, and IFN-g,
including increases in genes encoding MHC molecules and
Ag-processing machinery, Stat1, Stat2, Irf1, Irf7, and Iﬁtm3
(Supplemental Table IA, which shows all genes that increased or
decreased signiﬁcantly). Interestingly, a number of IFN-g–induced
guanylate-binding proteins (Gbp2, Gbp3, Gbp6, Gbp7, and Iﬁ47)
and IFN-g–induced GTPases (Iigp1, Irgm1, Irgm2, and Igtp) were
among the most increased genes postinfection, suggesting a
dominant IFN-induced change in gene expression. GSEA using
the Gene Ontology Biological Process database revealed that the
top 20 enriched gene sets were all related to innate and adaptive
immune responses, cytokine signaling, type I IFN, IFN-g, and
leukocyte activation (Supplemental Table IC). In contrast, very
few genes were signiﬁcantly downregulated after MCMV infec-
tion (Supplemental Table IA). There were no signiﬁcant changes
in expression of integrins or cell adhesion molecules that survived
correction for multiple testing errors (false discovery rate [FDR]
FIGURE 4. CD8+ T cell accumulation in infected and uninfected salivary glands is dependent on a4 integrin and chemokines. (A and B) Naive OT-I
T cells (5 3 104) were transferred into congenic mice that were infected 1 d later with MCMV expressing OVA via the i.p. route. Splenocytes containing
expanded OT-I T cells were recovered from the spleen 5 d later and transferred to mice infected with WT MCMV (lacking OVA) (A) or naive mice (B).
Recipients were treated or not with anti-a4 blocking Ab on the day of the transfer, and mice were sacriﬁced 2 d after the transfer. Data show the absolute
number of OT-I T cells recovered from the parenchyma of the salivary gland (SG) and the small intestine lamina propria (LP), as well as from the overall
CD8b+ fraction of the spleen (SPL). Results were combined from two independent experiments (n = 5 or 6 mice per group). (C) Naive B6 mice were seeded
with 8 3 106 in vitro–activated OT-I T cells that had been treated with PTx or vehicle as a control before the adoptive transfer. Shown are the absolute
numbers of OT-I T cells recovered from the parenchyma of the SG, kidneys (KDN), and lymph nodes (LN), as well as from the overall CD8b+ T cell
population of the SPL 4 d after the adoptive transfer. Results from two independent experiments were combined (n = 7). Error bars represent the SEM. *p ,
0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001, unpaired t test after log10 conversion of the absolute numbers.
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, 0.05), although expression of the a4, aL (CD11a), aX (CD11c),
and b2 integrins was increased in the infected salivary glands
when the gene set was ﬁltered by a raw p value , 0.05
(Supplemental Table IB, which shows all genes, regardless of
signiﬁcance).
Of the chemokines, expression of CCL5 and CXCL9 was sig-
niﬁcantly increased by infection (FDR , 0.05) and CCL7, CCL8,
CCL12, and CXCL10 were also detected when we used a raw p
value cutoff of 0.05 (Fig. 5, Supplemental Table IA, IB). In
contrast, several chemokines were abundantly expressed in the
salivary gland, regardless of infection, including CCL28,
CXCL12, CXCL14, CXCL16, CXCL17, and CX3CL1 (Fig. 5,
Supplemental Table IB). All of these chemokines, with the ex-
ception of CXCL17, have been described to recruit T cells in
various settings (29, 57–69). These data show that MCMV in-
fection of the salivary gland induces a dominant inﬂammatory
response centered on IFN-stimulated gene expression. However,
several chemokines were abundantly expressed in the salivary
gland, regardless of infection.
MCMV-speciﬁc T cells express multiple chemokine receptors
and are able to migrate toward multiple chemokines
To test whether MCMV-speciﬁc T cells could migrate to some of
the chemokines that were present in the salivary gland indepen-
dently of infection, we conducted Transwell migration assays
in vitro with the top six most abundantly expressed chemokines,
along with CCL5, CXCL9, CXCL10, and CCL19. T cells were
harvested from the spleens of mice 7 d after MCMV infection,
which represents the peak of T cell clonal expansion (34, 70) and a
time at which splenic T cells migrate readily to the salivary gland
in adoptive-transfer experiments (data not shown). In multiple
experiments, CCL28 and CXCL16 failed to induce any migration
of splenic CD8+ T cells (data not shown). In contrast, robust CD8+
T cell migration was induced by CCL19 (∼9-fold increased over
background, data not shown), but most of these cells were
CD44low, as expected (data not shown), and there was no increase
in tetramer-binding MCMV-speciﬁc T cells among the migrated
cells (Fig. 6A). All of the other tested chemokines induced sig-
niﬁcant migration of MCMV-speciﬁc T cells (Fig. 6A, 6B). These
included chemokines that were expressed at high levels constitu-
tively (CXCL12, CXCL14, CXCL17, and CX3CL1), as well as
chemokines induced in the salivary gland by infection (CXCL9,
CXCL10, and CCL5) (Fig. 6). These data show that MCMV-
speciﬁc T cells can migrate in vitro toward several chemokines
that are induced by MCMV infection or constitutively expressed
in the salivary gland.
Next, we used ﬂow cytometry to explore chemokine receptor
expression by OT-I T cells in the spleen and salivary gland 7–9 d
after MCMV-OVA infection. Cells were further differentiated by
KLRG1 expression, because our previous data showed that most
KLRG1-expressing T cells failed to accumulate in the paren-
chyma of the salivary gland (11). Seven to nine days after MCMV-
OVA infection, KLRG1-expressing splenic OT-I T cells were
mostly CX3CR1+ CXCR32, which is consistent with recent
studies (71, 72). Additionally, we found that these KLRG1+ cells
expressed CXCR6 but mostly lacked CXCR4 (Fig. 7A). In con-
trast, KLRG12 splenic OT-I T cells contained subsets expressing
or lacking CX3CR1, and a higher frequency of KLRG12 cells
expressed CXCR3, CXCR4, and CXCR6 (Fig. 7A). Of note, these
phenotypes were consistent: at 7 mo after MCMV infection,
KLRG1 expression on MCMV-speciﬁc T cells still correlated with
the expression of CX3CR1 and a lack of CXCR3 (data not
shown).
Within the parenchyma of the salivary gland, the majority of
cells lacked CX3CR1 and KLRG1 (Fig. 7B, left panel). In sharp
contrast, T cells found in the vasculature of the salivary gland
(i.e., stained by the intravascular Ab) were almost entirely
CX3CR1+, and most also expressed KLRG1 (Fig. 7B, right panel).
We have had difﬁculty getting consistent staining of any other
chemokine receptors on T cells extracted from the salivary glands.
In our hands, CXCR3 has been sensitive to the collagenase used to
extract T cells from the salivary gland, and attempts at extracting
T cells without collagenase have failed to result in sufﬁcient T cell
recovery. Therefore, we measured the expression of chemokine
receptors on T cells sorted from the spleen and salivary gland
using reverse transcriptase quantitative PCR (RT-qPCR). Naive
WT OT-I T cells were transferred into congenic mice and driven to
expand with a MCMV-OVA infection. Seven days later, OT-I
T cells sorted from the spleen and salivary gland expressed
CX3CR1, CCR5, CXCR3, CXCR4, and CXCR6 (Fig. 7C, 7D). In
contrast, CCR10 (receptor for CCL28) and CXCR7 (one receptor
for CXCL14) were undetectable on spleen- or salivary gland–lo-
calized OT-I T cells (data not shown). Interestingly, although
salivary gland– and spleen-localized T cells expressed comparable
amounts of CXCR3 and CCR5, salivary gland–localized T cells
expressed more CXCR4 (p = 0.016) and CXCR6 (p = 0.023) than
spleen-localized T cells. In contrast, spleen-localized T cells
expressed much more CX3CR1 than salivary gland–localized
T cells (p , 0.0001, Fig. 7C, 7D), consistent with our FACS data.
CXCR3 is critical for T cell migration to uninfected salivary
glands but is dispensable after MCMV infection
Because MCMV infection induced chemokines that bind CCR5
and CXCR3, we directly tested whether these receptors were
critical for the accumulation of MCMV-speciﬁc T cells in the
salivary gland. To this end, OT-I T cells that expressed or lacked
either receptor were mixed with their WT counterparts and
cotransferred to congenic B6 recipients. Recipient mice were in-
fected on the following day with MCMV expressing OVA. Two
FIGURE 5. Chemokine proﬁle of the salivary gland after MCMV in-
fection. The array of chemokines expressed in the salivary glands of un-
infected mice or mice 14 d after MCMV infection. Shown are the sample
reads per kilobase per million reads (RPKM) of chemokines to illustrate
the relative abundance of different transcripts. The complete list of genes
that were signiﬁcantly differentially expressed is shown in Supplemental
Table IA. The complete gene list sorted by fold change, regardless of
signiﬁcance, is shown in Supplemental Table IB. Data are from one ex-
periment (n = 3 mice per group). Error bars represent the SEM. ↑p , 0.05,
*FDR , 0.05.
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weeks after the infection, there were only small reductions in the
numbers of CXCR3-KO or CCR5-KO OT-I T cells in the salivary
gland (Fig. 8A, 8C), and these small differences were mirrored in
the spleens of the same animals, implying no impairment in the
recruitment of T cells lacking CXCR3 (Fig. 8A) or CCR5
(Fig. 8C) receptor. Moreover, there were no differences in the
absolute numbers of OT-I T cells that expressed the tissue-resident
markers CD69 and CD103 in the gland (Fig. 8B, 8D).
It was possible that CCR5 and CXCR3 played redundant roles in
the migration of T cells to the salivary gland during MCMV in-
fection. To address this possibility, WTand CCR5-KO OT-I T cells
were activated in vitro and transferred into infected mice, with or
without an Ab speciﬁc for CXCR3 that has been reported to block
CXCR3-dependent cell migration (73, 74). For infection, we used
the K181 strain of MCMV lacking OVA, again to avoid the in-
ﬂuence of Ag and additional T cell expansion after adoptive
transfer. However, donor OT-I T cells still migrated to the salivary
gland in all cases, and the absolute number of T cells in the gland
was similar in both groups, independently of the CXCR3 blockade
(Fig. 8F). There was a subtle difference in the overall number
between WT OT-I T cells in the unblocked group and CCR5-KO
OT-I T cells in the CXCR3-blocked group, possibly suggesting a
combined impact of CXCR3 and CCR5 on T cell migration.
However, the effect was subtle, and CXCR3 blockade had an
impact in the spleen in all mice. Therefore, it is difﬁcult to dis-
tinguish whether this effect was partially due to differences in
T cells in circulation (Fig. 8F). There was no impact of CCR5
deﬁciency, with or without CXCR3 blockade, on T cell migration
to lungs or kidneys. Although it is possible that CXCR3 blockade
was poorly effective in vivo in infected mice, these data suggest
that CCR5 and CXCR3 are not required for T cell accumulation in
infected salivary glands.
As a control for these experiments, we transferred in vitro–ac-
tivated WT OT-I T cells to naive recipients, with or without
CXCR3 blockade. Surprisingly, in naive mice, CXCR3 blockade
had a striking impact on T cell accumulation in the salivary gland
(Fig. 9), resulting in an ∼9-fold reduction in the numbers of OT-I
T cells that reached the parenchyma (Fig. 9B). Although the
blockade had an impact on the numbers of OT-I T cells in the
spleen, as in infected mice (Fig. 8F), it was weaker than the im-
pact on the salivary gland in naive mice, and there was no effect
on the T cells recovered from the lungs or kidneys (Fig. 9B).
These data imply that the CXCR3 blockade was effective in naive
mice and suggest that it was having a speciﬁc impact on T cell
accumulation in the salivary glands of naive mice, despite the
absence of an effect in infected mice.
To conﬁrm these surprising results, as well as to determine
whether CXCR3 was needed on T cells speciﬁcally, CXCR3-KO
and WT OT-I T cells were activated in vitro, mixed together, and
cotransferred to naive mice. Four days after transfer, the absolute
numbers of each OT-I population was assessed, and the ratio of
KO/WT cells was calculated within the parenchyma and the circu-
lation. In linewith our blockingAb data, accumulation of CXCR3-KO
OT-I T cells in the salivary gland was markedly impaired in two
separate experiments (Fig. 9D, 9E). Together, these data strongly
imply that T cell migration to, as well as accumulation in, unin-
fected salivary glands critically depends on CXCR3.(Figure legend continues)
FIGURE 6. MCMV-speciﬁc CD8+ T cells migrate toward multiple chemokines. Mice were sacriﬁced 7 d after i.p. MCMV infection. CD8+ T cells were
enriched and used to perform Transwell migration assays with multiple chemokines. Assays were performed with replicates, and media control was included in
each assay to account for plate-to-plate variation. (A) Absolute numbers of MCMV-speciﬁc T cells (M45 Tetramer+ plus M38 Tetramer+) that migrated toward
the indicated chemokine in comparison with control wells containing media and cells, but no chemokine. Data are from a single experiment performed
in triplicate or quadruplicate and are representative of two to ﬁve experiments per chemokine. (B) Fold change in migration in comparison with media.
Pooled data from two to four independent experiments indicating the fold change of migration of MCMV-speciﬁc cells (M45 Tetramer+ plus M38 Tetramer+)
in response to the indicated chemokines at the concentrations shown in (A). *p , 0.05, **p , 0.01, ***p , 0.001, paired t test.
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CXCL9 is expressed in the salivary gland at steady-state, even
in the absence of IFN-g
Because the ligands for CXCR3 (CXCL9 and CXCL10 in B6mice)
are strongly induced by IFN-g and upregulated by MCMV in-
fection (Fig. 5), we wished to conﬁrm that these ligands were
present in naive mice and test whether IFN-g was required for
T cell migration to the salivary gland. The chemokine CXCL9 was
readily detectable by ELISA and RT-qPCR in the salivary glands
of naive B6 and was also evident in IFN-g–KO mice (Fig. 9F, 9G).
In addition, when in vitro–activated OT-I T cells were transferred
to naive IFN-g–KO or B6 mice, they reached the salivary gland in
similar numbers (Fig. 9H). Thus, CXCL9 is available for T cell
recruitment to uninfected salivary glands, with or without infec-
tion or IFN-g. Collectively, these data suggest that the integrin
a4b1 and the chemokine receptor CXCR3 play critical roles in the
recruitment of T cells to uninfected or noninﬂamed salivary glands
but that CXCR3 is redundant during inﬂammation induced by
MCMV infection.
Discussion
The salivary gland is an important site of viral infection for transmission
to new hosts. Indeed, all betaherpesviruses and gammaherpesviruses
infect the salivary gland and are shed into saliva. Moreover, herpes-
viruses like CMVestablish latency in the salivary gland and reactivate
readily in this site during periods of immune suppression, particularly
when CD8+ T cells have been depleted (9). Therefore, it is important to
understand the mechanisms that promote and establish CD8+ T cell
residency in the salivary gland.
Recent studies have shown that salivary gland–localized T cells
can become TRM that reside near or within the epithelial layer
(10, 11). Interestingly, the mechanisms governing TRM formation
and maintenance differ in different tissues (75). Although TGF-b
is described as critical for promoting CD103-expressing TRM in
most tissues tested to date, including the salivary gland, a role for
Ag and inﬂammation is more variable (10, 11, 15, 21, 25, 76). Ag
seems to be required for the formation of CD103+ TRM in the CNS
and lungs (19, 20, 77). In the skin, the efﬁciency of T cell re-
cruitment is poor without local inﬂammation, and Ag improves
TRM maintenance, as well as the selection of TRM speciﬁcities (16, 24).
In contrast, TRM can form in the small intestine independently
of Ag, infection, or commensal microbiota. In fact, Ag in the
small intestine may reduce expression of CD103 on T cells that
reach this tissue (28). Remarkably, like the small intestine, the
salivary gland seems capable of recruiting activated T cells in the
absence of a speciﬁc infection or inﬂammation (10–12). In fact,
our data show that naive uninfected salivary glands and those with
an active MCMV infection were equally capable of recruiting
activated T cells over a period of 31 d (Fig. 3). These data suggest
that the salivary gland and small intestine may represent a set of
tissues that is continuously surveyed by activated T cells and is
capable of inducing their retention through constitutive TGF-b
FIGURE 7. Most CD8+ T cells in the parenchyma of the salivary gland lack KLRG1 and CX3CR1 but express multiple other chemokine receptors. Naive
OT-I T cells (2 3 103) were transferred to naive B6 mice that were infected i.p. 1 d later with MCMV expressing OVA. Mice were sacriﬁced 7 or 9 d
postinfection. (A) Chemokine receptor expression within the KLRG1+ and KLRG12 subsets of OT-I T cells in the spleen. (B) KLRG1 and CX3CR1
expression of OT-I T cells from the vasculature (I.V.+) and parenchyma (I.V.2) portions of the salivary gland. Data show concatenated FACS plots from one
representative experiment at day 9 (n = 3), with mean 6 SEM values in each quadrant derived from all experiments (total n = 8). (C and D) Naive OT-I
T cells were transferred as in (A) and sorted from the spleen (C) and the salivary gland (D) 7 d postinfection with MCMV expressing OVA. Chemokine
receptor expression was assessed on sorted T cells by RT-qPCR. Data were combined from two to ﬁve independent RT-qPCR assays per sample, with
cDNA from OT-I T cells sorted from two to three independent mice. Error bars represent SEM.
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expression. T cell recruitment to naive and infected salivary
glands depended on the a4 integrin (Fig. 4), whereas recruitment
to naive salivary glands depended on the chemokine receptor
CXCR3 (Fig. 9). These results imply that sufﬁcient levels of
VCAM-1 and CXCR3 ligands are expressed at steady-state in the
salivary gland for T cell recruitment. Indeed, CXCL9 was de-
tectable in the salivary glands of naive B6 mice, and its expression
was not dependent on IFN-g (Fig. 9). These data establish a
mechanism for the recruitment of activated T cells to the salivary
gland, regardless of infection.
Given that CXCL9 is classically thought of as an IFN-g–induced
chemokine, it is interesting that it was constitutively expressed in
the salivary gland. It is possible that animal colony conditions or
husbandry practices within our animal colony contribute to the
constitutive expression of CXCL9 that we observed (Fig. 9) and
the constitutive ability of naive salivary glands to recruit T cells
(Fig. 3). However, the recruitment of T cells to the salivary gland
in naive mice has been demonstrated in two other laboratories (10,
12), suggesting that our results cannot be explained by housing
conditions in the Thomas Jefferson University animal facility. It
must be noted that the salivary gland ducts are open to the oral
cavity and, therefore, are likely to be colonized by the oral
microbiome. Thus, it is possible that CXCL9 expression is a direct
response to oral microbiota. Interestingly, several chemokines,
including CXCL9, CXCL10, and CXCL11, can have antimicrobial
functions (78–80). Therefore, it is possible that T cell recruitment is
secondary to the antimicrobial role of chemokines in the salivary
gland and perhaps other digestive tissues. It will be fascinating in
future work to determine whether CXCL9 levels, as well as the
steady-state recruitment of activated T cells to the salivary gland,
are controlled by the oral microbiome.
Although CXCR3 appears to play a crucial role in the recruit-
ment of T cells to naive salivary glands, it is important to note that
our experiments did not test whether CXCL9 and CXCL10 were
required to recruit activated T cells to the naive or infected salivary
glands. Indeed, it is possible that CXCR3 was being activated by
alternative ligands in naive mice or that CXCL9 and CXCL10
could use alternative chemokine receptors in infected mice.
Moreover, heterodimerization of chemokines, as well as hetero-
dimerization of receptors, has been described and can increase the
breadth of potential ligand/receptor interactions (81, 82). There-
fore, extensive future work will be needed to tease apart the
speciﬁc ligand/receptor interactions involved in T cell recruitment
in different settings.
Although infected salivary glands recruited activated OT-I
T cells more rapidly, we observed a plateau in recruitment
(Fig. 3). It is possible that the ultimate numbers of TRM that ac-
cumulated in the salivary gland may have depended on the po-
tential of the T cells induced by in vitro activation. In our hands,
a subset of in vitro–activated OT-I T cells expressed CXCR3,
CXCR4, and/or CXCR6, and the population, as a whole, almost
completely lacked CX3CR1 (data not shown), much like our
FIGURE 8. Lack of CXCR3 or CCR5 does not impact the accumulation of CD8+ T cells in the salivary gland after MCMV infection. (A and C) WT OT-I
T cells and OT-I T cells that lacked the chemokine receptor CXCR3 or CCR5 were mixed (1 3 103 of each) and cotransferred to naive B6 mice that were
subsequently infected with MCMV-OVA. Overall numbers of CXCR3-KO (A) or CCR5-KO (C) OT-I T cells versus WT OT-I T cells from the spleen (SPL)
and the parenchyma of the salivary gland (SG) 14 d postinfection. (B and D) Absolute numbers of CD103+ CD69+ OT-I T cells from the SG. Data are
combined from two independent experiments for each KO/WT pair (n = 7 for WT/CXCR3 experiments, n = 5 for WT/CCR5 experiments). (E) Experi-
mental design of the OT-I adoptive transfer for (F). WT and CCR5-KO OT-I T cells were activated in vitro, and 4 3 106 of each were mixed. Mixed cells
were treated with anti-CXCR3 Ab or an isotype control and cotransferred to MCMV-infected mice that were treated with anti-CXCR3 or an isotype control
Ab via i.p. injection every other day starting 2 d before the adoptive transfer. (F) Absolute numbers of WT (solid bars) or CCR5-KO (striped bars) OT-I
T cells in the parenchyma of the salivary gland (SG), lungs (LG), and kidneys (KDN), as well as from the overall CD8b+ T cells from the spleen (SPL) of
CXCR3-blocked (+) or isotype control–treated (-) mice. Data are from two independent experiments (n = 7 for the isotype-treated group, n = 8 for the
CXCR3-treated group). Error bars represent that SEM. The statistical signiﬁcance was measured by an unpaired t test after log10 conversion of the absolute
numbers (A–D) and by one-way ANOVA (F). *p , 0.05, **p , 0.01. n.s., not signiﬁcant.
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MCMV-speciﬁc T cells in the salivary gland (Fig. 7). However, we
cannot exclude the possibility that only a subset of activated OT-I
T cells was capable of migrating to the salivary gland and be-
coming TRM, which could simulate a plateau in OT-I TRM num-
bers in the salivary gland over time. However, if such a limit in
cell numbers existed, it was unlikely to be caused by competition
for space or environmental cues in the salivary gland. New OT-I or
VACV-speciﬁc TRM were able to form in the salivary glands of
mice previously infected with MCMV (Fig. 2, data not shown),
despite the fact that infected salivary glands contained 20–30-fold
more T cells than naive salivary glands (data not shown). To-
gether, these experiments suggest that the salivary gland can ac-
commodate more TRM than were induced in our experimental
systems. Nevertheless, it is possible that pre-existing TRM in the
salivary gland would be reduced over time in animals exposed to
repeated infections. Thus, it will be exciting to learn how salivary
gland–localized TRM populations would evolve over time in re-
sponse to multiple different infections.
FIGURE 9. CXCR3 blockade reduces the recruitment of CD8+ T cells to salivary glands in uninfected mice independently of IFN-g. (A) WT OT-I T cells
were activated in vitro and treated with anti-CXCR3 Ab or isotype control, and 4 3 106 cells were transferred to naive mice. The recipients were also
treated with anti-CXCR3 Ab or isotype control every other day, starting 2 d before transfer until sacriﬁce. (B) Absolute numbers of OT-I T cells that reached
the parenchyma of the salivary gland (SG), lungs (LG), and kidneys (KDN), as well as from the CD8b+ population of the spleen (SPL). Data are from two
independent experiments (n = 7 for the isotype-treated group, n = 8 for the group treated with anti-CXCR3). (C) Experimental design for (D) and (E). WT
and CXCR3-KO OT-I T cells were activated in vitro, and 4 3 106 of each were mixed and cotransferred to naive mice. (D and E) Ratio of KO/WT OT-I
T cells in the vasculature (I.V.2) and parenchyma (I.V.+) of the SG, KDN, and SPL, as well as from the overall CD8b+ cells in the blood. Two independent
experiments are shown [n = 4 in (D), n = 5 in (E)]. The dashed lines represent the ratio of KO/WT cells in the transferred pool (as assessed by FACS on the
day of transfer). The levels of CXCL9 in the SG of naive B6 and IFN-g–KO mice were determined by RT-qPCR (F) and ELISA (G). Data are from one
experiment [n = 2 or 3 (F), n = 3 or 4 (G)]. (H) WT OT-I T cells were activated in vitro, and 43 106 T cells were transferred to naive B6 or IFN-g–KO mice
[similarly to (A and B)]. Four days after transfer, the organs were collected; the overall numbers of OT-I T cells in the SG, KDN, and SPL are shown. Data
are pooled from two independent experiments (n = 6 B6 mice, n = 7 IFN-g–KO mice). Error bars represent the SEM. For (A) and (H), statistical signiﬁcance
was measured by an unpaired t test after log10 conversion of the absolute numbers. For (D) and (E), the ratio of KO to WT cells was compared between the
blood, the IV1 and the IV2 fractions of each organ using a nonparametric Mann–Whitney test. *p , 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001.
n.s., not signiﬁcant.
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Our data showed that most KLRG1-expressing MCMV-speciﬁc
T cells upregulated CX3CR1 but lost CXCR3 expression and
failed to migrate into the salivary gland, even during MCMV infection
(Fig. 7). However, CXCR3 deﬁciency did not preclude MCMV-
speciﬁc T cells from the salivary gland during infection (Fig. 8).
Thus, presumably the loss of CXCR3 alone was not responsible for
the inability of these T cells to migrate into the salivary gland.
Moreover, a lack of the a4 integrin cannot explain the failure of these
cells to enter the salivary gland, because we have seen comparable
expression of a4 integrin on KLRG1
+ and KLRG2 MCMV-speciﬁc
T cells (data not shown). These results were surprising to us, but also
broadly consistent with research by Pircher and colleagues (32) that
suggested that CXCR3 was dispensable for CD8+ T cell migration to
the salivary gland after lymphocytic choriomeningitis virus strain WE
(LCMV-WE) infection. LCMV-WE is reported to not infect the
salivary gland directly (12), and it is unclear whether CXCR3 ligands
in the salivary gland are increased by LCMV-WE infection. Re-
gardless, it is certain that other changes induced by infection will
contribute to the efﬁciency and speed of T cell recruitment. Indeed,
LCMV-WE infection was associated with an increase in VCAM-1 on
the salivary gland vascular endothelium that likely facilitated the
recruitment of T cells. Thus, it is possible that MCMV infection re-
duced the burden on CXCR3 by increasing additional molecules that
are involved in the recruitment of T cells. Another possible expla-
nation is that MCMV infection induced an array of chemokines that
could redundantly recruit T cells. We tested whether CCR5 and
CXCR3 were acting together to recruit T cells by blocking CXCR3
on CCR5-KO T cells. However, these results should be interpreted
cautiously. Although CXCR3 blockade reduced T cell recruitment to
the salivary gland in naive mice, it is unclear whether the Ab was
fully able to block the CXCR3 receptor in infected mice, which likely
have many more CXCR3-expressing cells. Future work will need to
explore the speciﬁc mechanisms used by T cells to enter the salivary
gland during acute MCMV infection.
In conclusion, our data show that the salivary gland is able to
constitutively recruit CD8+ T cells in a a4 integrin– and CXCR3-
dependent manner and subsequently induce and sustain TRM
populations in the absence of infection, Ag, or inﬂammation.
Thus, it is plausible to think that the TRM populations in the sal-
ivary gland, and perhaps other tissues in the digestive tract, will
retain a record of previous infections and their speciﬁcities, re-
gardless of whether those infections were related to the salivary
gland. Moreover, the fact that CXCR3 was critical for recruitment
of T cells to naive salivary glands should be useful for guiding the
future development of vaccines that aim to establish or boost the
mucosal immune responses in the salivary gland.
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